Hunter CA - Search Results

1

Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27.

Villarino AV, Hunter CA. Villarino AV, et al. Among authors: hunter ca. Arthritis Res Ther. 2004;6(5):225-33. doi: 10.1186/ar1227. Epub 2004 Aug 16. Arthritis Res Ther. 2004. PMID: 15380038 Free PMC article. Review.

2

Cytokines and T cells in host defense.

Hunter CA, Reiner SL. Hunter CA, et al. Curr Opin Immunol. 2000 Aug;12(4):413-8. doi: 10.1016/s0952-7915(00)00110-2. Curr Opin Immunol. 2000. PMID: 10899023 Free article. Review.

3

Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli.

Mason N, Aliberti J, Caamano JC, Liou HC, Hunter CA. Mason N, et al. Among authors: hunter ca. J Immunol. 2002 Mar 15;168(6):2590-4. doi: 10.4049/jimmunol.168.6.2590. J Immunol. 2002. PMID: 11884420

4

The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii.

Lieberman LA, Hunter CA. Lieberman LA, et al. Among authors: hunter ca. Int Rev Immunol. 2002 Jul-Oct;21(4-5):373-403. doi: 10.1080/08830180213281. Int Rev Immunol. 2002. PMID: 12486820 Review.

5

Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.

Tato CM, Villarino A, Caamaño JH, Boothby M, Hunter CA. Tato CM, et al. Among authors: hunter ca. J Immunol. 2003 Mar 15;170(6):3139-46. doi: 10.4049/jimmunol.170.6.3139. J Immunol. 2003. PMID: 12626571

6

The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection.

Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA. Villarino A, et al. Among authors: hunter ca. Immunity. 2003 Nov;19(5):645-55. doi: 10.1016/s1074-7613(03)00300-5. Immunity. 2003. PMID: 14614852 Free article.

7

An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth.

Rankin EB, Yu D, Jiang J, Shen H, Pearce EJ, Goldschmidt MH, Levy DE, Golovkina TV, Hunter CA, Thomas-Tikhonenko A. Rankin EB, et al. Among authors: hunter ca. Cancer Biol Ther. 2003 Nov-Dec;2(6):687-93. Cancer Biol Ther. 2003. PMID: 14688478

8

Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

Artis D, Johnson LM, Joyce K, Saris C, Villarino A, Hunter CA, Scott P. Artis D, et al. Among authors: hunter ca. J Immunol. 2004 Apr 15;172(8):4672-5. doi: 10.4049/jimmunol.172.8.4672. J Immunol. 2004. PMID: 15067040

9

Understanding the pro- and anti-inflammatory properties of IL-27.

Villarino AV, Huang E, Hunter CA. Villarino AV, et al. Among authors: hunter ca. J Immunol. 2004 Jul 15;173(2):715-20. doi: 10.4049/jimmunol.173.2.715. J Immunol. 2004. PMID: 15240655 Review.

10

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA. Lieberman LA, et al. Among authors: hunter ca. J Immunol. 2004 Aug 1;173(3):1887-93. doi: 10.4049/jimmunol.173.3.1887. J Immunol. 2004. PMID: 15265921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

577 results

Search Page

Filters